In addition, AML patients with high expression of MEIS1 had a shorter survival time than those exhibiting low MEIS1 expression, and high MEIS1 level was associated with an inadequate response to conventional chemotherapy [87]. Here, MEIS1 is linked to acute myeloid leukemia.